Particle Data Platform

Samsung Joins The Trillion Dollar Club

5/6/20263 min

Plus: Novo Nordisk rallies on strong sales of its weightloss pill. And President Trump pauses the U.S. operation to guide commercial ships through the Strait of Hormuz.

Sign up for WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript preview

First 90 seconds
  1. Speaker 00:00

    Your teams spend more time searching for information than using it. Amazon Quick changes that. One intelligent assistant that connects all your company's data and turns answers into action instantly. aws.com/quick.

  2. Daniel Bock· Host0:14

    [instrumental music] Here's your morning brief for Wednesday, May 6th. I'm Daniel Bock for The Wall Street Journal. President Trump has said the US would pause its operation to guide commercial ships through the Strait of Hormuz. Project Freedom, as it's being called, began on Monday, prompting Iran to fire at ships in the waterway and target energy facilities in the United Arab Emirates. Trump said, quote, "Great progress had been made toward a peace agreement with Tehran," though he also said that a preexisting effort to blockade Iranian ports will continue. Shares in Novo Nordisk have rallied after first quarter sales surged 30%. It marks a turnaround for the maker of weight loss drug Wegovy, which has been locked in stiff competition with US rival Eli Lilly and trying to offset a bruising obesity drug price war. But Novo said the launch of its obesity pill is the best volume launch of a GLP-1 product ever, with over 2 million people already on prescription. Whether this growth will continue in the coming quarters will partly depend on the success of Eli Lilly's weight loss pill, which only launched at the end of the first quarter. And Korean tech giant Samsung has joined a rare league of companies worth more than a trillion dollars. Its shares have more than doubled so far this year, thanks to AI's red-hot demand for its memory chips. Its

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.